{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:44:11Z","timestamp":1790095451286,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903532"],"award-info":[{"award-number":["81903532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115333","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T17:28:34Z","timestamp":1692379714000},"page":"115333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2\/GPX4 pathway"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3822-2651","authenticated-orcid":false,"given":"Minling","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2023.115333_bib1","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2215\/CJN.15611219","article-title":"AKI!Now initiative: recommendations for awareness, recognition, and management of AKI","volume":"15","author":"Liu","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115333_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115333_bib3","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1681\/ASN.2014030262","article-title":"Regulated cell death in AKI","volume":"25","author":"Linkermann","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1681\/ASN.2021121591","article-title":"Cisplatin-induced kidney injury: delivering the goods","volume":"33","author":"Curry","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115333_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071572","article-title":"Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations","volume":"13","author":"McSweeney","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2023.115333_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24712-6","article-title":"Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury","volume":"12","author":"Tonnus","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2023.115333_bib7","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1172\/JCI129903","article-title":"Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule","volume":"129","author":"Deng","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2023.115333_bib8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.biopha.2023.115333_bib9","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115333_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2023.115333_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jcp.29903","article-title":"Involvement of GPX4 in irisin's protection against ischemia reperfusion-induced acute kidney injury","volume":"236","author":"Zhang","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115333_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03362-4","article-title":"Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2023.115333_bib14","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2023.115333_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jare.2020.07.007","article-title":"Quercetin alleviates acute kidney injury by inhibiting ferroptosis","volume":"28","author":"Wang","year":"2021","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2023.115333_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4776243","article-title":"Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2\/Slc7a11 Axis-Mediated Ferroptosis","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/med.21751","article-title":"Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol","volume":"41","author":"Lu","year":"2021","journal-title":"Med Res Rev."},{"issue":"6","key":"10.1016\/j.biopha.2023.115333_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0666-y","article-title":"Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2023.115333_bib19","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1007\/s12274-021-3894-x","article-title":"Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment","volume":"15","author":"Wu","year":"2022","journal-title":"Nano Res"},{"key":"10.1016\/j.biopha.2023.115333_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ebiom.2018.09.031","article-title":"Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-kappaB and improving mitochondrial function","volume":"36","author":"Yu","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.biopha.2023.115333_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1696-9","article-title":"FGF1(DeltaHBS) ameliorates chronic kidney disease via PI3K\/AKT mediated suppression of oxidative stress and inflammation","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115333_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2215\/CJN.12191213","article-title":"Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications","volume":"10","author":"Alge","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm.4012","article-title":"Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice","volume":"22","author":"Arai","year":"2016","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.biopha.2023.115333_bib24","article-title":"Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease","volume":"11","author":"Fontecha-Barriuso","year":"2022","journal-title":"Antioxid. (Basel)"},{"issue":"9","key":"10.1016\/j.biopha.2023.115333_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1523-1755.1998.00767.x","article-title":"In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity","volume":"53","author":"Baliga","year":"1998","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115333_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02745-1","article-title":"Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2\/HO-1 pathway","volume":"19","author":"Li","year":"2021","journal-title":"J. Transl. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.115333_bib28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/ajt.15773","article-title":"Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis","volume":"20","author":"Yamada","year":"2020","journal-title":"Am. J. Transpl."},{"issue":"7","key":"10.1016\/j.biopha.2023.115333_bib29","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.7150\/thno.54113","article-title":"Ferroptosis as a novel therapeutic target for cardiovascular disease","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.biopha.2023.115333_bib30","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115333_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102382","article-title":"Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes","volume":"54","author":"Kim","year":"2022","journal-title":"Redox Biol."},{"issue":"15","key":"10.1016\/j.biopha.2023.115333_bib32","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1111\/bph.15834","article-title":"Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway","volume":"179","author":"Hu","year":"2022","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bph.15283","article-title":"Targeted inhibition of Rev-erb-alpha\/beta limits ferroptosis to ameliorate folic acid-induced acute kidney injury","volume":"178","author":"Guo","year":"2021","journal-title":"Br. J. Pharm."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2023.115333_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.freeradbiomed.2022.10.320","article-title":"Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15\/Nrf2 signaling","volume":"193","author":"Li","year":"2022","journal-title":"Free Radic. Biol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115333_bib35","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.biopha.2023.115333_bib36","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jcmgh.2022.02.009","article-title":"Hepatic TGFbetar1 deficiency attenuates lipopolysaccharide\/D-galactosamine-induced acute liver failure through inhibiting GSK3beta-Nrf2-mediated hepatocyte apoptosis and ferroptosis","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.115333_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102349","article-title":"Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation","volume":"53","author":"Xu","year":"2022","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115333_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.115333_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105572","article-title":"Celastrol in metabolic diseases: progress and application prospects","volume":"167","author":"Xu","year":"2021","journal-title":"Pharm. Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.115333_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","article-title":"Targeting apoptosis pathways in cancer by Chinese medicine","volume":"332","author":"Li-Weber","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.115333_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.07.013","article-title":"Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury","volume":"349","author":"Qin","year":"2022","journal-title":"J. Control Release"},{"issue":"5","key":"10.1016\/j.biopha.2023.115333_bib42","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:51:39Z","timestamp":1782370299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223011241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"alternative-id":["S0753332223011241"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115333","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2\/GPX4 pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115333"}}